Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-22-009220
Filing Date
2022-03-11
Accepted
2022-03-11 19:09:03
Documents
2
Period of Report
2022-03-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1417
2 EXHIBIT 24 brhc10035141_ex24.htm EX-24 8281
  Complete submission text file 0001140361-22-009220.txt   11155
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Issuer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Malik Fady Ibraham (Reporting) CIK: 0001551778 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36829 | Film No.: 22734704